Rankings · Capital

Insiders buying

Companies whose directors, officers and largest holders bought more shares on the open market than they sold over the last twelve months, from SEC Form 4 filings, ranked by the net amount bought. Share grants and option exercises are left out.

37 companies meet this test

Figures as of November 15, 2026

#CompanyGradeNet bought by insidersInsiders buyingMarket value
1IMVTImmunovant, Inc.not rated$348.3M1$7.1B
2SGPSpyGlass Pharma, Inc.not rated$221.5M15$1.1B
3KYMRKYMERA THERAPEUTICS, INC.F-$107.9M1$10.9B
4SNDASonida Senior Living, Inc.D$100M1$1.6B
5STAASTAAR Surgical CoB$62.8M2$1.3B
6KODKODIAK SCIENCES INC.not rated$60M1$7.3B
7MANEVeradermics, Incnot rated$58.1M5$5.5B
8GENBGenerate Biomedicines, Inc.not rated$50.3M6$1.6B
9AHCOAdaptHealth Corp.C-$48.8M5$1B
10BHCBausch Health Companies Inc.A$15.5M1$3.1B

More rankings

A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.